• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    113.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    145張
  • 產業
    上櫃 生技醫療類股▼0.59%

  • 40人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
共信-KY (6617)籌碼相關－富邦-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

富邦-南京 券商分點個股進出

富邦-南京 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/0200.005112.70113.50-5144-3.45%
2024/12/3100.0016.5116.33113.50-16.5144-11.38%
2024/12/300.1110.5000.00112.500.11380.07%
2024/12/271110.5000.00110.5011380.72%
2024/12/261114.0000.00111.5011370.73%
2024/12/1800.004.5110.46110.00-4.5134-3.31%
2024/12/1700.004108.00108.00-4133-3.00%
2024/12/1200.001104.00103.00-1136-0.73%
2024/12/061109.508107.00107.50-7148-4.71%
2024/12/051111.5000.00110.5011500.66%
2024/12/031112.0000.00113.0011660.60%
2024/11/291114.0000.00115.0011730.58%
2024/11/281115.5000.00113.5011780.56%
2024/11/271119.009117.12118.50-8180-4.43%
2024/11/261114.0000.00114.0011840.54%
2024/11/2500.001112.50110.50-1188-0.53%
2024/11/191104.5000.00108.0012370.42%
2024/11/132.1109.7400.00108.502.12560.82%
2024/11/114116.0000.00113.0042661.50%
2024/11/086119.580.2117.50115.005.82682.17%
2024/11/071.2117.504.7116.60117.50-3.5266-1.33%
2024/10/2500.001106.50107.00-1292-0.34%
2024/10/231109.0000.00107.0012970.34%
2024/10/221111.5000.00110.5012990.33%
2024/10/150.1111.001110.00111.50-0.9320-0.28%
2024/10/110.2110.0000.00109.000.23240.06%
2024/10/071116.505114.20112.50-4326-1.22%
2024/10/040.1115.501114.50116.00-1330-0.29%
2024/10/0100.003115.00117.00-3334-0.90%
2024/09/241119.5000.00119.5013650.27%
2024/09/200.2121.6700.00121.000.23900.04%
2024/09/1900.001118.50122.50-1402-0.25%
2024/09/181119.001123.00120.5004280.00%
2024/09/130.2123.5000.00122.500.25120.03%
2024/09/120126.0000.00124.5005240.01%
2024/09/091124.501126.00126.0005600.00%
2024/09/050.4129.1900.00126.000.45590.08%
2024/09/040.1125.500.3131.00133.50-0.3556-0.04%
2024/09/030.2130.381130.00129.50-0.8547-0.14%
2024/08/302.1132.1400.00129.502.15500.39%
2024/08/292131.7500.00131.5025510.36%
2024/08/281135.001131.50133.5005650.00%
2024/08/261127.501124.00125.5005550.00%
2024/08/232.2129.3300.00126.002.25520.39%
2024/08/2200.000130.50129.0005430.00%
2024/08/211118.0000.00121.5015280.19%
2024/08/201104.001109.00113.0005120.00%
2024/08/1900.001100.00103.00-1510-0.20%
2024/08/161101.0000.00101.0015060.20%
2024/08/15198.500.299.2298.500.85020.16%
2024/08/14398.40598.8696.50-2499-0.40%
2024/08/1300.002103.00101.00-2491-0.41%
2024/08/1200.002101.75101.50-2492-0.41%
2024/08/091103.9900.00102.0014900.21%
2024/08/070110.501100.50108.50-1484-0.20%
2024/08/062.1104.4019101.29103.50-16.9471-3.58%
2024/08/050.2113.181114.50112.00-0.8464-0.18%
2024/08/020.1128.501128.00124.00-0.9461-0.20%
2024/07/301.1130.0500.00132.501.14540.24%
2024/07/290.1130.5000.00130.000.14520.02%
2024/07/260.2138.5000.00136.000.24480.04%
2024/07/230.3137.0000.00140.500.34450.06%
2024/07/220.4140.7500.00138.500.44420.09%
2024/07/191143.503143.67142.00-2437-0.46%
2024/07/181143.501138.00141.0004270.00%
2024/07/171135.501136.00136.0004180.00%
2024/07/162138.251137.50136.0014160.24%
2024/07/111135.001135.00135.0004090.00%
2024/07/101.1135.951135.00135.000.14080.02%
2024/07/082.3137.3500.00135.002.34090.56%
2024/07/053.1138.5500.00139.503.14040.77%
2024/07/041.8142.531144.00140.000.84020.20%
2024/07/033136.880.1144.02143.002.93930.74%
2024/07/027.1140.2500.00137.507.13831.85%
2024/07/019.3145.5100.00142.509.33782.45%
2024/06/280.1148.0000.00147.000.13730.01%
2024/06/270.1148.5000.00147.000.13690.03%
2024/06/260.7156.004156.00153.00-3.3357-0.92%
2024/06/252.1143.451.1143.55147.5013420.29%
2024/06/245.1151.971155.50147.004.13291.24%
2024/06/212.2157.775157.40160.00-2.8300-0.93%
2024/06/202.2139.919141.56146.50-6.9253-2.70%
2024/06/197.1130.4500.00128.507.12143.31%
2024/06/186.2132.4200.00132.006.21993.10%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨－2024/08/24
...詳全文
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨－2024/07/31
...詳全文
共信孫公司向農業部防檢局申請 動物用新藥藥證審查UDN聯合新聞網－2024/07/30
共信-KY（6617）30日公告，孫公司共信寵物生醫已向農業部防檢局申請動物用新成分新藥「思沛康注射液」藥證審查（NAD......詳全文
共信-KY 相關文章
共信-KY 相關影音